| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
